clinical trials
The $9.4 Billion Bet on Code: Why Thermo Fisher’s Mega-Deal for a Software Company Is Reshaping Medicine
Thermo Fisher’s $9.4B acquisition of Clario isn’t just a deal; it’s a bet on the future of medicine, powered by software, AI, and cloud technology.
The $600M Bet: How the Global Race for Weight-Loss Drugs is Rewriting the Rules of Biotech Investing and Tapping into China’s R&D Power
A US biotech’s $600M raise for weight-loss drugs reveals a key strategy: using China for faster, cheaper clinical trials, altering biotech investing.